Cellebrite DI Ltd. (NASDAQ:CLBT) Short Interest Up 5.9% in October

Cellebrite DI Ltd. (NASDAQ:CLBT) was the recipient of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 1,430,000 shares, a growth of 5.9% from the September 30th total of 1,350,000 shares. Based on an average trading volume of 1,260,000 shares, the short-interest ratio is presently 1.1 days. Currently, 2.3% of the company’s shares are sold short.

Cellebrite DI Stock Down 0.6 %

Shares of NASDAQ CLBT opened at $18.36 on Thursday. The stock has a market cap of $3.78 billion, a price-to-earnings ratio of -34.64, a P/E/G ratio of 2.52 and a beta of 1.52. Cellebrite DI has a twelve month low of $6.55 and a twelve month high of $18.75. The company’s fifty day moving average is $17.38 and its 200-day moving average is $13.91.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings data on Thursday, August 15th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. The business had revenue of $95.70 million for the quarter, compared to analysts’ expectations of $91.94 million. Cellebrite DI had a negative net margin of 28.51% and a positive return on equity of 5,902.06%. The firm’s revenue was up 24.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.05 EPS. On average, research analysts anticipate that Cellebrite DI will post 0.31 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CLBT. Needham & Company LLC lifted their target price on shares of Cellebrite DI from $14.00 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Craig Hallum lifted their target price on shares of Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. TD Cowen lifted their target price on shares of Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, September 23rd. Bank of America lifted their price target on shares of Cellebrite DI from $13.00 to $17.00 and gave the stock a “buy” rating in a research report on Friday, August 16th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Cellebrite DI from $15.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, August 16th. Eight investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Cellebrite DI has an average rating of “Buy” and a consensus target price of $18.57.

Institutional Investors Weigh In On Cellebrite DI

Several institutional investors have recently added to or reduced their stakes in CLBT. Janney Montgomery Scott LLC lifted its position in Cellebrite DI by 240.1% in the 1st quarter. Janney Montgomery Scott LLC now owns 45,300 shares of the company’s stock valued at $502,000 after acquiring an additional 31,981 shares in the last quarter. Capstone Investment Advisors LLC acquired a new stake in Cellebrite DI in the 1st quarter valued at $870,000. GSA Capital Partners LLP increased its stake in Cellebrite DI by 574.0% in the 1st quarter. GSA Capital Partners LLP now owns 286,930 shares of the company’s stock valued at $3,179,000 after buying an additional 244,357 shares during the last quarter. Quantbot Technologies LP increased its stake in Cellebrite DI by 97.7% in the 1st quarter. Quantbot Technologies LP now owns 124,199 shares of the company’s stock valued at $1,376,000 after buying an additional 61,365 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in Cellebrite DI by 34.8% in the 1st quarter. SG Americas Securities LLC now owns 51,881 shares of the company’s stock valued at $575,000 after buying an additional 13,392 shares during the last quarter. 45.88% of the stock is owned by institutional investors.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.